Amid a torrent of drug and product recalls from Big Pharma and consumer giants, the name of a tiny lab in Connecticut keeps popping up. Its name is Valisure, and its efforts to warn consumers about potentially dangerous items have infuriated manufacturers and irked the federal regulator that they fund.

Read more: A Tiny Lab Finds Danger on Drugstore Shelves While the FDA Lags Behind - https://www.bloomberg.com/news..../features/2022-11-09

The US Food and Drug Administration is supposed to make sure the medications we take are effective–and safe. But when a small independent lab in Connecticut called Valisure started testing popular drugs and health products, it turned up some alarming results–including carcinogens and other dangerous substances. You might think the FDA would welcome this information. Not so fast.

Bloomberg reporter Anna Edney joins Big Take to talk about how Valisure’s findings have shined a light on serious flaws in the way medications are tested and approved. Valisure CEO David Light talks with Wes about how his lab identifies harmful substances in products, and how the FDA responded when he came forward with his lab’s findings. Then Dr. Diana Zuckerman, President of the National Center for Health Research, stops by to answer the question: Is the FDA too close to the companies it oversees? Listen on Apple Podcasts: https://podcasts.apple.com/us/....podcast/the-tiny-lab

Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK

0:00 - 1:37: Regulators and drug safety
1:38 - 2:46: Valisure’s independent testing
2:47 - 4:22: NDMA in Zantac
4:23 - 4:49: Future of drug safety
4:50 - 5:22: Benzene in personal care products
5:23 - 6:21: Valisure and the FDA
6:22 - 7:05: Testing for Benzene contamination
7:06 - 8:19: Future studies and shortages
8:20 - 8:53: Statements

#Health #Documentary #Bloomberg
--------
Like this video? Subscribe: http://www.youtube.com/Bloombe....rg?sub_confirmation=

Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subs....criptions?in_source=

Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.

Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.

Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.